Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

A double-pronged attack on advanced prostate cancer could help treat as many as two in five patients with late-stage disease, ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone ...

Prostate cancer treatment could be "supercharged" by a new way of weakening malignant cells, say scientists in Australia.

Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...

It is not unusual for advanced prostate cancer to become resistant to treatment. Of these resistant cases, some progress to a ...

A new study suggests cholesterol-lowering statins, when combined with apalutamide and hormone therapy, can significantly ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society.

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with ...

From AI-generated biopsy reports to new imaging techniques, these are the latest developments in advanced prostate cancer research that your doctor may be keeping tabs on. Much of managing advanced ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

Statin use linked to better survival but higher cardiac adverse events in advanced prostate cancer patients treated with ...